Source: Medicines Authority (MT) Revision Year: 2023 Publisher: Viatris Healthcare Limited, Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland
Rantudil forte 60 mg hard capsules.
Pharmaceutical Form |
---|
Hard capsule; colour of the upper capsule shell is L 570 red (orange-brown), colour of the lower capsule shell is opaque yellow (yellow-beige); size 4. |
Each hard capsule contains 60 mg acemetacin.
Other ingredients with known effects: Each hard capsule contains 73.9 mg lactose-monohydrate.
For a full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Acemetacin |
Acemetacin is a glycolic acid ester of indomethacin and the pharmacological activity resulting from acemetacin administration in man is derived from the presence of both acemetacin and indomethacin. The precise pharmacological mode of action of acemetacin is not known. However, unlike other NSAIDs, acemetacin is only a relatively weak inhibitor of prostaglandin synthetase. |
List of Excipients |
---|
Ferric oxy-hydroxide hydrate (E172) |
Package with 20 hard capsules.
Package with 50 hard capsules.
Package with 100 hard capsules.
Not all package sizes may be placed on the market.
Viatris Healthcare Limited, Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland
MA1507/01801
Date of first authorisation: 18 January 2008
Date of latest renewal: 30 November 2012
Drug | Countries | |
---|---|---|
RANTUDIL | Germany, Croatia, Japan, Malta, Mexico, Poland, Turkey |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.